Latest news
Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 06:30:00 GMTThe Bull Case For NiSource (NI) Could Change Following Q2 Profit Drop Despite Higher Revenue - Yahoo Finance UKYahoo Finance UK · Mon, 10 Aug 2026 02:10:00 GMTWhy Playtika Holding (PLTK) Could Be 42% Undervalued Following Reaffirmed 2026 Guidance - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 02:08:00 GMTThe Bull Case For Kimbell Royalty Partners (KRP) Could Change Following Record Q2 2026 Results And 15% Distribution Hike - Yahoo FinanceYahoo Finance · Sun, 09 Aug 2026 22:16:55 GMTIs Alexander's (ALX) A Bargain Following Its Earnings And Dividend News? - Yahoo FinanceYahoo Finance · Sun, 09 Aug 2026 20:11:32 GMTWhy Walker & Dunlop (WD) Could Be 28% Below Fair Value Following Earnings - Yahoo FinanceYahoo Finance · Sun, 09 Aug 2026 18:10:13 GMTMach Natural Resources (MNR) Could Be 30% Below Fair Value Following Q2 Beat - Yahoo Finance SingaporeYahoo Finance Singapore · Sun, 09 Aug 2026 15:10:39 GMTIs Ormat Technologies (ORA) Undervalued Following Its Raised 2026 Outlook And Earnings Beat? - Yahoo FinanceYahoo Finance · Sun, 09 Aug 2026 14:10:54 GMT